LESCHLY MARK

Director at SENOMYX INC · on record since Jan 30, 2006
Director at NITROMED INC · on record since May 19, 2006
10% owner at Vanda Pharmaceuticals Inc. · on record since Apr 18, 2006
Director at TERCICA INC · on record since Jun 16, 2006
Director at DIVERSA CORP · on record since Jul 24, 2006
10% owner at NITROMED INC · on record since Dec 18, 2006
10% owner at ADVANCIS PHARMACEUTICAL CORP · on record since Apr 16, 2007
10% owner at BLUEFLY INC · on record since Dec 22, 2009
Director at BLUEFLY INC · on record since Feb 26, 2010
10% owner at ReachLocal Inc · on record since May 25, 2010
10% owner at IntraLinks Holdings, Inc. · on record since Aug 11, 2010
Director at Anacor Pharmaceuticals Inc · on record since Nov 23, 2010
10% owner at Anacor Pharmaceuticals Inc · on record since Nov 23, 2010
10% owner at TERCICA INC · on record since Nov 24, 2003
10% owner at Cara Therapeutics, Inc. · on record since Jan 30, 2014
10% owner at Everyday Health, Inc. · on record since Mar 27, 2014
Director at NephroGenex, Inc. · on record since Feb 19, 2014
10% owner at NephroGenex, Inc. · on record since Feb 19, 2014
10% owner at · on record since Feb 25, 2015
10% owner at · on record since Mar 7, 2005
Director at · on record since May 17, 2019
Director at · on record since Mar 23, 2021
10% owner at · on record since Feb 8, 2021

Insider trading activity of LESCHLY MARK

Transactions on record: 170; since Nov 12, 2003

Open-market buys: 8; $36.8M

Open-market sells: 9; $1.5M

Companies traded: 11; last filing Jul 22, 2026

Figures computed from official regulatory filings — .

Companies where LESCHLY MARK has traded

12 tx · Jul 22, 2026
7 tx · Jun 10, 2021
4 tx · $11.6M · Apr 3, 2017
3 tx · $46.2M · Dec 6, 2016
26 tx · $12.4M · Jun 24, 2016
2 tx · $5.3M · Nov 15, 2012
57 tx · $21.6K · Apr 28, 2009
9 tx · Feb 18, 2009
22 tx · $36M · Oct 20, 2008
26 tx · $3.1M · Jun 4, 2007
2 tx · $5M · Apr 16, 2007

Track record of LESCHLY MARK

Statistical track record

Free

Open-market buys: 9

Last buy: Mar 31, 2017

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of LESCHLY MARK

Co-insiders of LESCHLY MARK

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ChargePoint Holdings, Inc.	Jul 22, 2026	Award	18,370	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 22, 2026	Award	6,680	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 22, 2026	Award	1,336	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 9, 2025	Award	254,785	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 11, 2024	Award	115,552	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 20, 2023	Award	21,925	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 14, 2022	Award	13,563	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 14, 2021	Award	3,192	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 2, 2021	Other	12,650	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Jun 10, 2021	AwardD (derivative)	19,619	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jun 1, 2021	Award	18,500	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Mar 23, 2021	Other	25,300	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Mar 2, 2021	Award	382,996	—	—	SEC
NGM BIOPHARMACEUTICALS INC	May 22, 2020	AwardD (derivative)	16,806	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	May 17, 2019	AwardD (derivative)	24,000	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	OtherD (derivative)	-600,000	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	Other	3,766,667	—	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	OtherD (derivative)	-3,000,000	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	OtherD (derivative)	-166,667	0.00 USD	—	SEC
Cara Therapeutics, Inc.	Apr 3, 2017	Buy	500,000	18.19 USD	$9.1M	SEC
Everyday Health, Inc.	Dec 6, 2016	Other	-4,397,630	10.50 USD	$46.2M	SEC
Everyday Health, Inc.	Dec 6, 2016	Other	-176,690	0.00 USD	—	SEC
Everyday Health, Inc.	Dec 6, 2016	OtherD (derivative)	-176,690	0.00 USD	—	SEC
Anacor Pharmaceuticals Inc	Jun 24, 2016	OtherD (derivative)	-15,000	—	—	SEC
Anacor Pharmaceuticals Inc	Jun 24, 2016	OtherD (derivative)	-24,000	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ChargePoint Holdings, Inc.	Jul 22, 2026	Award	18,370	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 22, 2026	Award	6,680	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 22, 2026	Award	1,336	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 9, 2025	Award	254,785	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 11, 2024	Award	115,552	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 20, 2023	Award	21,925	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 14, 2022	Award	13,563	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 14, 2021	Award	3,192	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jul 2, 2021	Other	12,650	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Jun 10, 2021	AwardD (derivative)	19,619	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Jun 1, 2021	Award	18,500	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Mar 23, 2021	Other	25,300	0.00 USD	—	SEC
ChargePoint Holdings, Inc.	Mar 2, 2021	Award	382,996	—	—	SEC
NGM BIOPHARMACEUTICALS INC	May 22, 2020	AwardD (derivative)	16,806	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	May 17, 2019	AwardD (derivative)	24,000	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	OtherD (derivative)	-600,000	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	Other	3,766,667	—	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	OtherD (derivative)	-3,000,000	0.00 USD	—	SEC
NGM BIOPHARMACEUTICALS INC	Apr 10, 2019	OtherD (derivative)	-166,667	0.00 USD	—	SEC
Cara Therapeutics, Inc.	Apr 3, 2017	Buy	500,000	18.19 USD	$9.1M	SEC
Everyday Health, Inc.	Dec 6, 2016	Other	-4,397,630	10.50 USD	$46.2M	SEC
Everyday Health, Inc.	Dec 6, 2016	Other	-176,690	0.00 USD	—	SEC
Everyday Health, Inc.	Dec 6, 2016	OtherD (derivative)	-176,690	0.00 USD	—	SEC
Anacor Pharmaceuticals Inc	Jun 24, 2016	OtherD (derivative)	-15,000	—	—	SEC
Anacor Pharmaceuticals Inc	Jun 24, 2016	OtherD (derivative)	-24,000	—	—	SEC